CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,735 | -97.7% | 2,009 | -98.1% | 0.00% | -100.0% |
| Q2 2023 | $2,346,285 | +263.5% | 105,451 | +253.9% | 0.01% | +200.0% |
| Q1 2023 | $645,490 | -76.8% | 29,801 | -78.2% | 0.00% | -80.0% |
| Q4 2022 | $2,777,677 | +40.9% | 136,764 | +77.9% | 0.02% | +25.0% |
| Q3 2022 | $1,971,000 | +160.7% | 76,883 | +141.7% | 0.01% | +100.0% |
| Q2 2022 | $756,000 | -17.3% | 31,804 | -21.6% | 0.01% | -25.0% |
| Q1 2022 | $914,000 | +9.3% | 40,566 | -3.9% | 0.01% | +33.3% |
| Q4 2021 | $836,000 | +43.2% | 42,225 | +42.3% | 0.01% | -14.3% |
| Q3 2021 | $584,000 | +54.1% | 29,665 | +86.2% | 0.01% | +16.7% |
| Q1 2021 | $379,000 | +7.1% | 15,935 | -24.4% | 0.01% | +20.0% |
| Q2 2020 | $354,000 | +128.4% | 21,070 | +62.1% | 0.01% | -16.7% |
| Q1 2020 | $155,000 | – | 13,002 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |